Tukysa (tucatinib) has been shown in studies to help reduce the risk of breast cancer growing or spreading and has helped those with advanced or metastatic HER2 positive breast cancer live longer, including people whose cancer has spread to their brain. HER2 is a protein that contributes to cancer cell growth.